Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $82.49 million. The enterprise value is $58.24 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, before market open.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 71.11 million shares outstanding. The number of shares has increased by 0.43% in one year.
| Current Share Class | 71.11M |
| Shares Outstanding | 71.11M |
| Shares Change (YoY) | +0.43% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 5.70% |
| Owned by Institutions (%) | 34.39% |
| Float | 59.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.39 |
| Forward PS | 232.16 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.25.
| Current Ratio | 4.72 |
| Quick Ratio | 4.30 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.95 |
Financial Efficiency
Return on equity (ROE) is -52.77% and return on invested capital (ROIC) is -29.98%.
| Return on Equity (ROE) | -52.77% |
| Return on Assets (ROA) | -26.71% |
| Return on Invested Capital (ROIC) | -29.98% |
| Return on Capital Employed (ROCE) | -60.98% |
| Revenue Per Employee | $289,174 |
| Profits Per Employee | -$1.63M |
| Employee Count | 23 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.85% in the last 52 weeks. The beta is 0.36, so OVID's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -0.85% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 57.47 |
| Average Volume (20 Days) | 1,506,474 |
Short Selling Information
The latest short interest is 1.27 million, so 1.79% of the outstanding shares have been sold short.
| Short Interest | 1.27M |
| Short Previous Month | 1.51M |
| Short % of Shares Out | 1.79% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 0.76 |
Income Statement
In the last 12 months, OVID had revenue of $6.65 million and -$37.52 million in losses. Loss per share was -$0.54.
| Revenue | 6.65M |
| Gross Profit | 6.65M |
| Operating Income | -41.77M |
| Pretax Income | -50.68M |
| Net Income | -37.52M |
| EBITDA | -41.21M |
| EBIT | -41.77M |
| Loss Per Share | -$0.54 |
Full Income StatementBalance Sheet
The company has $38.35 million in cash and $14.10 million in debt, giving a net cash position of $24.25 million or $0.34 per share.
| Cash & Cash Equivalents | 38.35M |
| Total Debt | 14.10M |
| Net Cash | 24.25M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 55.79M |
| Book Value Per Share | 0.78 |
| Working Capital | 33.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.07 million and capital expenditures -$18,000, giving a free cash flow of -$40.09 million.
| Operating Cash Flow | -40.07M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -40.09M |
| FCF Per Share | -$0.56 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -628.09% |
| Pretax Margin | -574.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.43% |
| Shareholder Yield | -0.43% |
| Earnings Yield | -45.48% |
| FCF Yield | -48.60% |
Analyst Forecast
The average price target for OVID is $3.13, which is 169.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.13 |
| Price Target Difference | 169.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 94.77% |
| EPS Growth Forecast (5Y) | 23.22% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of -5.42 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.42 |
| Piotroski F-Score | 1 |
